BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $243.68M in the quarter ending June 30, 2026, with 120.39% growth. This brings the company's revenue in the last twelve months to $713.07M, up 202.39% year-over-year. In the year 2025, BridgeBio Pharma had annual revenue of $502.08M with 126.26% growth.

• Revenue (ttm): $713.07M
• Revenue Growth: +202.39%
• P/S Ratio: 19.86
• Revenue / Employee: $710,936
• Employees: 1,003
• Market Cap: 14.16B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	502.08M	280.17M	126.26%
Dec 31, 2024	221.90M	212.60M	2,285.27%
Dec 31, 2023	9.30M	-68.35M	-88.02%
Dec 31, 2022	77.65M	7.93M	11.38%
Dec 31, 2021	69.72M	61.47M	745.14%
Dec 31, 2020	8.25M	-32.31M	-79.66%
Dec 31, 2019	40.56M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-

Data Source: Fiscal.ai Last updated: Aug 10, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 12, 2026

Data Sources Report a data error